Filing Details
- Accession Number:
- 0001085146-20-001824
- Form Type:
- 13D Filing
- Publication Date:
- 2020-07-20 14:47:00
- Filed By:
- Glacier Point Advisors, Llc
- Company:
- Phenixfin Corp (NYSE:PFX)
- Filing Date:
- 2020-07-20
- SEC Url:
- 13D Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Glacier Point Advisors | 0 | 0 | 0 | 6,023,239 | 6,023,239 | 11.06% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Medley Capital Corporation
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
58503F106
(CUSIP Number)
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
July 20, 2020
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject
of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. [X]
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with
respect to the subject class of securities, and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page
The information required on the remainder of this cover page shall not be deemed to be filed for the purposes of
Section 18 of the Securities Exchange Act of 1934 (the Act) or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however, see the Instructions).
CUSIP No.: 58503F106
| ITEM 1. | SECURITY AND ISSUER: |
| Medley Capital Corporation | |
| ITEM 2. | IDENTITY AND BACKGROUND: |
| 280 Park Avenue, 6th Floor East, New York, NY 10017 | |
| ITEM 3. | SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION: |
| ITEM 4. | PURPOSE OF TRANSACTION: |
| The Reporting Persons acquired shares of the Common Stock for investment purposes. The Reporting Persons, in their ordinary course of business, regularly review their equity interest in the issuer. While the reporting persons have no present intention to dispose of all or any portion of the Common Stock beneficially owned by them, any such sales of the Common Stock may be made in the open market, privately negotiated transactions, or otherwise. Depending on their assessment of the of the forgoing factors, the reporting persons may, from time to time, further modify their present intention as stated in this item 4. In addition, they may at their discretion purchase additional shares of common stock. Kevin McCallum, Registered Investment Advisor with Glacier Point Advisors, LLC has indicated his interest in being appointed to the Board of Medley Capital Corp., along with Howard Amster and Matthew Howlett, as independent directors and has proposed that the Board consider, as part of its strategic review process to seek enhanced shareholder value, a plan to repurchase stock and debt of the Company in a manner that would be accretive, and maximize value to the Company's shareholders, using proceeds from cash, loan maturities and asset sales. Glacier Point Advisors, LLC believes that implementing such a strategy is the best approach to increasing net asset value and thereby in turn, enhance shareholder value. Although Messrs. Amster and Howlett may share common interests with Glacier Point Advisors, LLC, we disclaim being part of any group with them. Except as set forth above, the Reporting Persons do not have at this time any specific plans which would result in (a) the acquisition by the Reporting Persons of additional securities of the Issuer or the disposition by the Reporting Persons of securities of the Issuer, other than described above (b)any extraordinary corporate transactions such as a merger, reorganization, or liquidation involving the Issuer or any of its subsidiaries, (c) any sale or transfer of a material amount of the assets of the Issuer or any of its subsidiaries; (d) any change in the present management of board of directors of the Issuer, including any plans or proposals to change the term of directors, or to fill any existing vacancies on the Issuer's board of directors: (e) any other material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure; (g)any change in the Issuer's charter, bylaws, or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) the Common Stock being delisted from a national securities exchange or ceasing to be authorized to be quoted in an inter-dealer quotation system or a registered national securities association;(i) causing a class of equity securities of the Issuer to be eligible for termination of registration pursuant to Section 129(g)(4)of the Act; or (j) any action similar to those enumerated above. | |
| ITEM 5. | INTEREST IN SECURITIES OF THE ISSUER: |
| ITEM 6. | CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER: |
| ITEM 7. | MATERIALS TO BE FILES AS EXHIBITS: |
| Exhibit A - Letter to Medley Capital Corp Directors dated July 20, 2020. |